Results 171 to 180 of about 198,729 (300)

Left Ventricular Hypertrophy [PDF]

, 2005
openaire   +1 more source

Left Ventricular Hypertrophy

Medicine & Science in Sports & Exercise, 2018
Gabriele Mascherini, Cristian Petri, Giorgio Galanti   +2 more
openaire   +2 more sources

Comparative diagnostic accuracy study of point of care ultrasound techniques for detection of left atrial enlargement by hospital medicine physicians from archived echocardiogram images

Journal of Hospital Medicine, EarlyView.
Abstract Background Left atrial enlargement (LAE) is predictive of cardiovascular morbidity and mortality. Prior studies of point‐of‐care ultrasound (POCUS) interpretation methods for identifying LAE utilized older echocardiographic reference ranges. Objectives Compare the test characteristics of hospitalist‐performed POCUS techniques for identifying ...
Christopher J. Smith, Jesse Umbra, Sofia Quintero, Austin Wilson, Elizabeth Lyden, Nidish Tiwari, Brian Shahan, Jana Wardian   +7 more
wiley   +1 more source

Added Value of Rotational Mechanics to Longitudinal Indices in the Risk Stratification of Patients With Left Ventricular Hypertrophy. [PDF]

Echocardiography
Geraldo J, Gil C, Queipo A, García-Martín G, Galiana E, Hidalgo A, Gramage P, Martinez-Navarro H, Lowenstein J, Roldán I, Mora V.   +10 more
europepmc   +1 more source

Pre‐Imaging Clinical Factors Associated With Cardiac MR Image Quality Using Large Language Model‐Enabled Data Extraction

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Poor cardiac MR image quality can prompt repeat examinations and hinder clinical decision‐making. Purpose To evaluate whether pre‐imaging clinical information, extracted using a large language model (LLM), is independently associated with cardiac MR image quality. Study Type Retrospective.
Hong Yu, Masha Bondarenko, Ali Nowroozi, Yoo Jin Lee, Adrian Serapio, Punita Kaveti, Jae Ho Sohn   +6 more
wiley   +1 more source

Deep learning-enabled ECG system for detecting left ventricular hypertrophy and predicting cardiovascular prognoses. [PDF]

BioData Min
Yang ZY, Hsing SC, Tsai DJ, Lin C, Lin CS, Wang CH, Fang WH.   +6 more
europepmc   +1 more source

MiR‐145‐5p Attenuates Doxorubicin‐Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Doxorubicin (DOX), a potent anthracycline chemotherapeutic, exhibits dose‐dependent cardiotoxicity that limits its clinical utility. Although miR‐145‐5p demonstrates cardioprotective properties in cardiovascular diseases, its role in DOX‐induced cardiomyopathy remains undefined.
Xing‐Tao Chen, Yong‐Hong Yu, Yan‐Hua Du, Lin Xu, Xiang‐Ping Meng   +4 more
wiley   +1 more source

A diagnostic challenge of advanced-stage cardiac Fabry disease without left ventricular hypertrophy: a case report. [PDF]

Eur Heart J Case Rep
Suzuki M, Yoshigai Y, Hashimura H, Aiba T, Ohno S, Osue T, Eizawa H, Tanaka H.   +7 more
europepmc   +1 more source

Alogliptin Reduces Oxidative Stress in Cardiomyocytes and Ameliorates Diabetic Cardiomyopathy via the AURKB/NLGN2 Signaling

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus. This study investigated the effects of alogliptin on DCM and its underlying mechanisms. A DCM model was constructed and treated with alogliptin. Downstream targets of alogliptin were screened using bioinformatics analysis.
Li‐Jing Jiao, Jing Zhou, Jing Wang, Si‐Nan Zhao, Zhan‐Sheng Zhao, Qian Wang, Ya‐Nan Xie, Wei Jiao   +7 more
wiley   +1 more source

Left ventricular hypertrophy and myocardial work in amateur marathon runners. [PDF]

Front Cardiovasc Med
Wang J, Tian H, Zeng Q, Cao S, Wang Y.
europepmc   +1 more source